Emerging Companies and Venture Capital

Representative Venture Capital Transactions

Over the years, our attorneys have participated nationally and abroad in numerous venture capital and angel financing transactions. We have substantial experience in representing every kind of participant in these financings and have provided guidance to our clients at every stage of the financing process. Our clients include companies seeking seed or angel financing, the parties that provide such financing, founders, and strategic investors. Our venture capital clients include national and international venture funds, public and private corporations, family offices, and individual investors that participate in industries such as biotechnology and life sciences, healthcare, information technology, artificial intelligence, internet of things, virtual reality, utilities and energy, food services, food safety, franchising, manufacturing, infrastructure, and transportation. Following is a list of some of the recent transactions in which our attorneys played a significant role.

• Represented Advanced BioHealing, Inc. in its preferred stock financing from investors led by Safeguard Scientifics, Inc. and in its debt financings from Horizon Technology and from Oxford Finance Corporation and Silicon Valley Bank.
• Represented Advent International and its associated venture capital funds in their equity investments in U.S. and Latin American services companies.
• Represented Advanced Orthopedic Technologies, Inc. in its convertible debt financing from Elm Street Ventures.
• Represented Affomix Corporation in its convertible debt financing from Elm Street Ventures and in its preferred stock financing from investors led by Connecticut Innovations, Incorporated and Elm Street Ventures.
• Represented AlloStem Therapeutics, LLC in its preferred equity financing from a group of angel investors.
• Represented Amastan Technologies in its Series A financing led by KLP Ventures and LaunchCapital as well as in its oversubscribed Series B financing led by Anzu Partners, Material Impact, and RKS Ventures.
• Represented Ancera in its Series A financing led by Glass Capital Management, Packers Sanitation Services, and Metabiota.
• Represented Applied Spine Technologies, Inc. in its preferred stock financings from investors led by Oxford Bioscience Partners, BioVenture Investors, InterWest Partners, DeNovo Ventures, Investor Growth Capital, and Memphis Biomed Ventures.
• Represented b-there.com in its preferred stock financings and convertible debt financings from investors led by CEA Capital Partners, Seaport Capital Partners, TL Ventures, and BancBoston Ventures.
• Represented BeCaid, LLC (also known as C8 Sciences) in its preferred equity financing from various investors.
• Represented Bernoulli Enterprises, Inc. in its Series A financing.
• Represented Cardiophotonics, LLC in its convertible debt financings from investors led by LaunchCapital.
• Represented CGI Pharmaceuticals, Inc. in its preferred stock financings from investors led by CHL Medical Partners, Lily Bioventures, CDP Capital, RiverVest Venture Partners, Toucan Capital Corporation, and MPM Bioventures.
• Represented CiDRA Holdings LLC in its preferred equity financings from investors led by HRLD; Teknoinvest Energy; Velocity Equity Partners; Axiom Venture Partners; Open Field Private Partners; Connecticut Innovations, Incorporated; Wheatley Partners; and Citron Capital and in its debt financing from Webster Bank.
• Represented CMD Bioscience, LLC in its convertible debt financing from investors led by LaunchCapital and Connecticut Innovations, Incorporated.
• Represented Cohen Private Ventures in an equity investment in DocASAP, Inc.
• Represented corporate venture investor in connection with its preferred stock strategic investment in a biometric signature identification company.
• Represented Desmos, Inc. in its convertible debt financings from investors led by Learn Capital Ventures, Kindler Capital, and Elm Street Ventures.
• Represented Emme E2MS, LLC in its preferred share financing from investors led by Connecticut Innovations, Incorporated.
• Represented Employ Insight, LLC in its preferred share financing from investors led by LaunchCapital and Club Circle Partners.
• Represented Floop, Inc. in its convertible debt financing from investors led by Advantage Capital and Enhanced Capital.
• Represented Fluid-Screen, Inc. in its Series A financing from venture capital investors.
• Represented GestVision in its Series A financing led by CooperSurgical.
• Represented Helix Therapeutics, Inc. in its preferred stock financings from investors led by Connecticut Innovations, Incorporated; Canaan Partners; and LaunchCapital and in its debt financing from Webster Bank.
• Represented Higher One, Inc. in its preferred stock financings from investors led by North Hill Ventures, Hanseatic Americas Inc., Inter-Atlantic Fund, Webster Financial Corporation, GML Investment Partners, Windcrest Partners, East Point Partners, Club Circle Partners, and Sachem Ventures.
• Represented HistoRx, Inc. in its preferred stock and convertible debt financings from investors led by Brook Ventures, Navigation Technology Ventures, Roche Finance, Commons Capital, and Connecticut Innovations, Incorporated.
• Represented Iconic Therapeutics, Inc. in its preferred stock financing from investors led by Diem Bioventures.
• Represented iDevices, LLC in its preferred equity financing from a group of angel investors and in its debt financing from Enhanced Capital.
• Represented iMedX, Inc. in its preferred stock financing from investors led by RFE Investment Partners.
• Represented Innovatient Solutions, Inc. in its preferred stock financing from investors led by Connecticut Innovations, Incorporated.
• Represented innRoad, Inc. in its convertible debt financing from a group of angel investors and in its preferred stock financing from investors led by Blue Heron Capital.
• Represented Iron Heart Acquisition, LLC in its Class A stock offering.
• Represented ISG Holdings, Inc. in its preferred stock financings from investors led by SV Life Sciences, Beecken Petty O’Keefe & Company, BB&T Capital Partners, and Audax Group and in its senior and mezzanine debt financings from various lenders.
• Represented Isoplexis Corporation in its Series B financing led by Spring Mountain Capital and including Connecticut Innovations, Incorporated; North Sound Ventures; and Ironwood Capital.
• Represented Keisense, Inc. in its convertible debt financing from Connecticut Innovations, Incorporated.
• Represented MedOptions in its preferred equity financings from Housatonic Equity Partners and Point Judith Ventures and in its debt financings from TD Bank and HV Capital.
• Represented NextCloud, Inc. in its preferred stock financing from investors led by Connecticut Innovations, Incorporated.
• Represented Mitotherapeutix, LLC in its convertible debt financing from Connecticut Innovations, Incorporated.
• Represented My Gene Counsel LLC in its convertible debt financing.
• Represented Occam Sciences, Inc. in its preferred stock financing from Elm Street Ventures.
• Represented P2 Science, Inc. in its equity financing from Elm Street Ventures and Yale University and in its convertible debt financing from Elm Street Ventures.
• Represented PaperG, Inc. in its convertible debt and preferred stock financings from investors led by Club Circle Partners, LaunchCapital, and Top Floor LLC.
• Represented PhytoCeutica, Inc. in its preferred stock financings from Asian institutional investors.
• Represented Point72 Asset Management, LP in its Series A investment in LVH, LLC.
• Represented Rallybio, LLC in its Series A financing led by 5AM Ventures, Canaan Partners, and New Leaf Venture Partners.
• Represented Retail Optimization, Inc. in its preferred stock and convertible debt financings from investors led by Connecticut Innovations, Incorporated; Elm Street Ventures; and Long River Ventures.
• Represented REvolution Computing, Inc. in its preferred stock financing from investors led by Intel Capital Corporation, North Bridge Venture Partners, and Middlefield Ventures.
• Represented an investor group in its equity investments in SeatGeek, Inc.
• Represented SeeClickFix, Inc. in its preferred stock financing from investors led by O’Reilly AlphaTech Ventures and Omidyar Network Fund LLC.
• Represented Shoreline Biome, LLC in its preferred equity financing led by Connecticut Innovation, Incorporated.
• Represented Silvergate Pharmaceuticals, Inc. in its preferred stock financing from investors led by Frazier Healthcare.
• Represented SJF Ventures in its equity investments in MediaMath, Inc. and ServiceChannel.com.
• Represented Somatix, Inc. in its Series A preferred stock financing.
• Represented SurgiQuest, Inc. in its preferred stock and convertible debt financings from investors led by CMEA Ventures, Aphelion Capital, California Technology Ventures, and Mosaix Ventures.
• Represented Tonix Pharmaceuticals, Inc. in its preferred stock financing from various investors.
• Represented VBrick Systems, Inc. in its preferred stock financings from investors led by RedShift Ventures, Menlo Ventures, Morgan Stanley Dean Witter Ventures, and Adams Capital Management.
• Represented a venture capital partnership in connection with its senior term loan to an established designer and manufacturer of specialty tools.
• Represented Wellinks in its seed financing.
• Represented Yale University in its debt investments in Axerion Therapeutics, Inc.

Representative Company Sale Transactions

• Mergers and Acquisitions Experience

Our attorneys handled all aspects of these transactions on behalf of our clients, providing initial advice on structuring each transaction, negotiating each transaction, and providing antitrust, intellectual property, securities, tax, labor and employment, and other advice.